X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6698) 6698
Newsletter (59) 59
Magazine Article (23) 23
Book Chapter (7) 7
Newspaper Article (3) 3
Book / eBook (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5507) 5507
thiophenes - therapeutic use (4524) 4524
female (2810) 2810
male (2797) 2797
middle aged (1867) 1867
animals (1636) 1636
thiophenes - pharmacology (1623) 1623
aged (1509) 1509
thiophenes - adverse effects (1403) 1403
adult (1296) 1296
thiophenes - administration & dosage (1264) 1264
pharmacology & pharmacy (1238) 1238
treatment outcome (1203) 1203
rivaroxaban (935) 935
duloxetine hydrochloride (911) 911
morpholines - therapeutic use (732) 732
anticoagulants - therapeutic use (694) 694
double-blind (683) 683
double-blind method (679) 679
rats (619) 619
prasugrel hydrochloride (596) 596
mice (590) 590
dose-response relationship, drug (579) 579
piperazines - therapeutic use (525) 525
administration, oral (517) 517
drug therapy (500) 500
dabigatran (499) 499
clinical trials as topic (471) 471
sulfonamides - therapeutic use (471) 471
efficacy (469) 469
aged, 80 and over (465) 465
drug therapy, combination (460) 460
duloxetine (440) 440
platelet aggregation inhibitors - therapeutic use (436) 436
ticlopidine - analogs & derivatives (435) 435
analysis (434) 434
medicine, general & internal (428) 428
care and treatment (421) 421
antidepressive agents - therapeutic use (416) 416
psychiatry (409) 409
thiophenes - pharmacokinetics (403) 403
randomized controlled trials as topic (400) 400
benzimidazoles - therapeutic use (397) 397
oncology (396) 396
cardiac & cardiovascular systems (392) 392
safety (389) 389
abridged index medicus (383) 383
medicine & public health (381) 381
risk factors (377) 377
beta-alanine - analogs & derivatives (376) 376
thiophene (375) 375
time factors (373) 373
thiophenes - chemistry (359) 359
antihypertensive agents - therapeutic use (348) 348
anticoagulants (343) 343
adolescent (340) 340
clopidogrel (331) 331
prevention (331) 331
ticlopidine - therapeutic use (322) 322
research (321) 321
clinical neurology (320) 320
serotonin uptake inhibitors - therapeutic use (318) 318
pyrazoles - therapeutic use (316) 316
neurosciences (313) 313
peripheral vascular disease (313) 313
anticoagulants - adverse effects (311) 311
morpholines - adverse effects (310) 310
hematology (301) 301
pyridones - therapeutic use (292) 292
depressive disorder, major - drug therapy (285) 285
internal medicine (283) 283
thiophenes (277) 277
hemorrhage - chemically induced (275) 275
organometallic compounds - therapeutic use (274) 274
beta-alanine - therapeutic use (273) 273
therapy (273) 273
endocrinology & metabolism (270) 270
prospective studies (267) 267
acute coronary syndrome - drug therapy (264) 264
stroke - prevention & control (264) 264
morpholines - administration & dosage (260) 260
risk (259) 259
venous thromboembolism (259) 259
intraocular pressure - drug effects (258) 258
warfarin (258) 258
disease models, animal (257) 257
anticoagulants - administration & dosage (255) 255
chemistry, medicinal (254) 254
ophthalmology (254) 254
clinical trials (252) 252
bone density conservation agents - therapeutic use (251) 251
drug administration schedule (251) 251
prasugrel (249) 249
cancer (248) 248
young adult (248) 248
factor xa inhibitors (247) 247
pharmacokinetics (247) 247
placebo (245) 245
health aspects (244) 244
osteoporosis (244) 244
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6166) 6166
German (204) 204
French (137) 137
Spanish (74) 74
Japanese (64) 64
Russian (54) 54
Italian (40) 40
Polish (26) 26
Chinese (15) 15
Czech (14) 14
Hungarian (10) 10
Croatian (6) 6
Danish (6) 6
Romanian (6) 6
Dutch (5) 5
Finnish (4) 4
Swedish (4) 4
Turkish (4) 4
Norwegian (3) 3
Portuguese (3) 3
Hebrew (2) 2
Serbian (2) 2
Slovak (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | ZOLEDRONIC ACID | SURGICAL ADJUVANT BREAST | ONCOLOGY | STATIN USE | LOW-DOSE TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | GENOME-WIDE ASSOCIATION | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 611 - 621
.... Anticoagulation uses 1 of 4 choices: bivalirudin, unfractionated heparin, enoxaparin, and fondaparinux... 
Cardiovascular | WORKING GROUP | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | EUROPEAN-SOCIETY | ELEVATION MYOCARDIAL-INFARCTION | CONSENSUS DOCUMENT | PLATELET REACTIVITY | ATRIAL-FIBRILLATION | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
Journal Article
Journal Article
Journal Article
The American journal of medicine, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article